Carregant...
Study design considerations for the Standardized Treatment Of Pulmonary exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF
BACKGROUND: Pulmonary exacerbations (PEx) in cystic fibrosis (CF) are common and contribute to morbidity and mortality. Duration of IV antibiotic therapy to treat PEx varies widely in the US, and there are few data to guide treatment decisions. METHODS: We combined a survey of CF stakeholders with r...
Guardat en:
| Publicat a: | Contemp Clin Trials |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742044/ https://ncbi.nlm.nih.gov/pubmed/29170074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.11.012 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|